Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
about
Acne vulgarisNeighborhood determinants of 2009 pandemic A/H1N1 influenza vaccination in Montreal, Quebec, Canada.Exposure to anti-infective drugs during pregnancy and the risk of small-for-gestational-age newborns: a case-control study.Isotretinoin exposure during pregnancy: a population-based study in The Netherlands.Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy.Congenital anomalies following use of isotretinoin: Emphasis on its legal aspects.Adverse drug reactions--no farewell to harms.Darier's disease: a calcium-signaling perspectiveEvaluation of biophysical skin parameters and assessment of hair growth in patients with acne treated with isotretinoin.The use of isotretinoin in low doses and unconventional treatment regimens in different types of acne: a literature review.Teratogenic exposures.Adverse effects of acne medications: recognition and management.Isotretinoin and the risk of cardiovascular, cerebrovascular and thromboembolic disorders.Chemical pharmacotherapy options for managing adult acne.Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance.Compliance with pregnancy prevention plan recommendations in 8672 French women of childbearing potential exposed to acitretin.Suggestions for effective contraception in isotretinoin therapy.Isotretinoin 5 mg daily for low-grade adult acne vulgaris--a placebo-controlled, randomized double-blind study.iPLEDGE allegiance to the pill: evaluation of year 1 of a birth defect prevention and monitoring system.Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study.Healthcare professional surveys to investigate the implementation of the isotretinoin Pregnancy Prevention Programme: a descriptive study.Retinol and Retinyl Palmitate.Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential.Isotretinoin; A review on the Utilization Pattern in PregnancyCarrier-based drug delivery system for treatment of acne
P2860
Q24634131-44E5E532-5E95-4950-865A-A4D7CB2CB756Q30422510-D6296BFF-BB26-4A52-B233-BA12BA53CB2EQ34199799-F3A0B055-846F-46E6-BCB7-B16F315BF462Q34573521-5F948D6B-9619-49C2-8D01-82BE2BF95040Q34584358-774D9916-1212-4EE8-BDBB-267A4083102DQ34677062-334625E7-C604-43CF-AB0E-E74DA3740B06Q34678660-FFEC452A-68C9-45DE-9BD8-477D7455E7F1Q36024353-0A442CB0-BEA7-43E2-A88D-75A4B340D108Q37020148-226EA036-3185-4116-9F70-AEE3471CB591Q37535723-6C02613F-F145-48E7-ADB4-1A591B9E1EF9Q37670635-B9DF9B0E-0179-46DC-A1A7-293B136D0C97Q37902128-DE8D79BB-ED21-4668-ACC4-028FFBBDB03FQ38432225-5B417C87-F44F-446E-B831-2A069EC1D735Q38437372-A61C36D1-4076-4A2C-8EF8-5DEC91D540D0Q39084169-27C647AD-E16C-40CF-934C-35D8040F2FD6Q41053834-7FA5EAA1-5904-457A-9189-5825D611D65AQ41263604-12173C0C-BDB5-4409-8E98-99B344C4B8D1Q43146756-13DA13E1-4FE5-49DF-A49A-AF82ADD0BD86Q43857644-020056CE-2B3C-4057-8E89-7B96EACA8E83Q46107861-CF48988E-B187-4C5E-BE8C-9B609527B5C2Q46143031-F64C5392-0A06-447D-BC99-00EB9531FDCDQ46869716-4226D0DC-439F-4B4E-9978-BB6E0D82077EQ50100655-DB196EBB-5A7B-45C5-A0D0-BBF4BCD30303Q51381921-F450C777-B91B-49A4-A702-827223A46104Q57136258-C3C06809-8831-4F76-AA87-38A467FBB996Q59075268-13AE55A5-EF1E-4BC7-8672-4B1B9ADE9AC5
P2860
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
@ast
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
@en
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
@nl
type
label
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
@ast
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
@en
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
@nl
prefLabel
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
@ast
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
@en
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
@nl
P2093
P2860
P1476
Isotretinoin, pregnancies, abortions and birth defects: a population-based perspective
@en
P2093
Anick Bérard
Driss Oraichi
Gideon Koren
Laurent Azoulay
Lucie Blais
Sylvie Perreault
P2860
P304
P356
10.1111/J.1365-2125.2006.02837.X
P407
P577
2007-02-01T00:00:00Z